Medicare Enrolled
Dr. Bradley Sumrall, MD
Optician · Macon, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sumrall from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sumrall?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sumrall
Dr. Bradley Sumrall is an optician specialist in Macon, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sumrall performed 201,257 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sumrall received a total of $34,895 from 70 pharmaceutical and/or device companies across 396 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sumrall is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 1% volume in GA
$34,895 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗201,257
Medicare services
Top 1% in GA for optician
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
39,750 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 32,601 | $43 | $140 |
| Nivolumab injection (Opdivo) | 15,980 | $24 | $38 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
14,900 | $0 | $1 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
11,100 | $0 | $3 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
10,786 | $0 | $13 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
10,620 | $38 | $75 |
| Denosumab injection (Prolia/Xgeva) | 9,960 | $18 | $34 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
9,330 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
5,942 | $6 | $25 |
| Paclitaxel chemotherapy injection | 5,896 | $0 | $1 |
| Bevacizumab biosimilar injection, 10 mg An injection of bevacizumab-awwb, a biosimilar medication, administered in a 10 mg dose. |
3,760 | $23 | $192 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,204 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,682 | $8 | $27 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
2,242 | $22 | $74 |
| Injection, docetaxel, 1 mg | 2,163 | $1 | $5 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
2,026 | $10 | $32 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,790 | $1 | $55 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,613 | $91 | $170 |
| Injection, leucovorin calcium, per 50 mg | 915 | $3 | $15 |
| Injection, granisetron hydrochloride, 100 mcg | 860 | $0 | $30 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
723 | $92 | $392 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
692 | $2 | $8 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
577 | $13 | $48 |
| Iron level test | 565 | $6 | $25 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
562 | $9 | $26 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
547 | $21 | $126 |
| Etoposide chemotherapy injection Administration of etoposide, a chemotherapy medication, via injection. The dose specified is 10 mg. |
544 | $1 | $16 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
519 | $10 | $69 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 510 | $3 | $137 |
| Injection, potassium chloride, per 2 meq | 500 | $0 | $1 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
420 | $58 | $130 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
418 | $129 | $215 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
407 | $2 | $11 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
341 | $6 | $17 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
318 | $15 | $96 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
305 | $16 | $91 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
298 | $14 | $61 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
295 | $44 | $185 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
259 | $2 | $7 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
255 | $11 | $60 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
216 | $1 | $1 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
215 | $20 | $92 |
| Cyclophosphamide, 100 mg | 215 | $16 | $87 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 208 | $127 | $898 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
204 | $112 | $590 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
175 | $5 | $20 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
169 | $17 | $70 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
163 | $6 | $34 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
161 | $46 | $682 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
154 | $46 | $195 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
145 | $14 | $36 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
142 | $158 | $947 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
140 | $7 | $22 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
121 | $52 | $163 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
120 | $1 | $6 |
| New patient office visit, complex (60-74 min) | 118 | $159 | $300 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
106 | $1 | $5 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
97 | $9 | $64 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
88 | $0 | $4 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
85 | $39 | $165 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
84 | $2 | $25 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
84 | $23 | $103 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
80 | $14 | $70 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
75 | $111 | $232 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
70 | $9 | $67 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
63 | $42 | $570 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
61 | $180 | $624 |
| Haptoglobin level test A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown. |
58 | $12 | $47 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
50 | $19 | $67 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
45 | $23 | $90 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
43 | $2 | $14 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
40 | $4 | $14 |
| CT scan of neck soft tissue with contrast A computed tomography scan that uses contrast dye to create detailed images of the soft tissues in the neck. |
37 | $52 | $535 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
36 | $9 | $70 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
34 | $68 | $614 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
34 | $61 | $110 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
32 | $5 | $16 |
| Injection, alteplase recombinant, 1 mg | 30 | $70 | $112 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
28 | $1 | $14 |
| Injection, furosemide, up to 20 mg | 26 | $0 | $3 |
| Total T3 thyroid hormone test A blood test that measures the total amount of triiodothyronine (T3) hormone in your body. T3 is a thyroid hormone that helps regulate metabolism and energy levels. |
18 | $14 | $54 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $100 | $236 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
20.8% high complexity
73.3% medium
5.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$34,895
Total received (2018-2024)
Avg $4,985/year across 7 years
Top 5% in GA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
396
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,649
2023
$2,096
2022
$5,700
2021
$10,012
2020
$6,177
2019
$5,341
2018
$3,921
Payments by company (2024)
Regeneron Healthcare Solutions, Inc.
$220
Janssen Scientific Affairs, LLC
$150
ABBVIE INC.
$109
Eisai Inc.
$94
Astellas Pharma US Inc
$91
Gilead Sciences, Inc.
$72
PFIZER INC.
$71
Merck Sharp & Dohme LLC
$68
Takeda Pharmaceuticals U.S.A., Inc.
$61
GENZYME CORPORATION
$59
AstraZeneca Pharmaceuticals LP
$58
Bayer Healthcare Pharmaceuticals Inc.
$56
Exelixis Inc.
$54
Daiichi Sankyo Inc.
$51
Stemline Therapeutics Inc.
$44
Incyte Corporation
$41
JAZZ PHARMACEUTICALS INC.
$38
PUMA BIOTECHNOLOGY, INC.
$37
Medtronic, Inc.
$31
ImmunoGen, Inc.
$27
BeiGene USA, Inc.
$21
Genmab U.S., Inc.
$20
Genentech USA, Inc.
$20
Ipsen Biopharmaceuticals, Inc
$18
Karyopharm Therapeutics Inc.
$18
Novartis Pharmaceuticals Corporation
$17
Mirati Therapeutics, Inc.
$17
Pharmacosmos Therapeutics Inc.
$16
Celgene Corporation
$15
ADC Therapeutics America, Inc.
$15
ARRAY BIOPHARMA INC
$14
Aveo Pharmaceuticals, Inc.
$14
Janssen Biotech, Inc.
$11
Top 3 companies account for 29.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$6,217
Gilead Sciences, Inc.
$4,711
Amgen Inc.
$3,508
Exelixis Inc.
$3,314
Kite Pharma, Inc.
$1,774
Seagen Inc.
$1,569
Celgene Corporation
$1,561
Janssen Global Services, LLC
$1,500
Eisai Inc.
$1,477
ARRAY BIOPHARMA INC
$1,312
Bayer HealthCare Pharmaceuticals Inc.
$944
Janssen Scientific Affairs, LLC
$908
Janssen Biotech, Inc.
$597
GlaxoSmithKline, LLC.
$481
Regeneron Healthcare Solutions, Inc.
$471
Merck Sharp & Dohme Corporation
$372
PFIZER INC.
$327
Astellas Pharma US Inc
$298
Novartis Pharmaceuticals Corporation
$288
Novocure GmbH
$200
ABBVIE INC.
$176
Genentech USA, Inc.
$169
Alexion Pharmaceuticals, Inc.
$150
AbbVie Inc.
$148
E.R. Squibb & Sons, L.L.C.
$140
Sirtex Medical Inc
$133
AbbVie, Inc.
$129
EISAI INC.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$125
GENZYME CORPORATION
$123
Heron Therapeutics, Inc.
$120
Merck Sharp & Dohme LLC
$120
BeiGene USA, Inc.
$96
ASD Specialty Healthcare, LLC
$90
Daiichi Sankyo Inc.
$87
ImmunoGen, Inc.
$80
AVEO Pharmaceuticals, Inc.
$74
Bayer Healthcare Pharmaceuticals Inc.
$72
Pharmacyclics LLC, an AbbVie Company
$69
Stemline Therapeutics Inc.
$69
Seattle Genetics, Inc.
$65
ADC Therapeutics America, Inc.
$63
Incyte Corporation
$52
CTI BioPharma Corp.
$39
MEDIVATION FIELD SOLUTIONS LLC
$38
JAZZ PHARMACEUTICALS INC.
$38
PUMA BIOTECHNOLOGY, INC.
$37
Medtronic, Inc.
$31
Deciphera Pharmaceuticals Inc.
$30
Mirati Therapeutics, Inc.
$30
Coherus Biosciences Inc.
$28
Rigel Pharmaceuticals, Inc.
$25
Adaptive Biotechnologies Corporation
$22
TESARO, Inc.
$22
Genmab U.S., Inc.
$20
Blueprint Medicines Corporation
$19
G1 Therapeutics, Inc.
$19
Ipsen Biopharmaceuticals, Inc
$18
Karyopharm Therapeutics Inc.
$18
NOVARTIS PHARMACEUTICALS CORPORATION
$17
Pharmacosmos Therapeutics Inc.
$16
Clovis Oncology, Inc.
$15
Servier Pharmaceuticals LLC
$15
Pharmacyclics LLC, An AbbVie Company
$15
Aveo Pharmaceuticals, Inc.
$14
Medtronic USA, Inc.
$13
Lexicon Pharmaceuticals, Inc.
$12
Global Blood Therapeutics, Inc.
$12
Flowonix Medical Incorporated
$12
EMD Serono, Inc.
$11
Top 3 companies account for 41.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Alecensa · Avastin · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CINVANTI · COSELA · Cabometyx · DARZALEX · ELAHERE · ELIQUIS · ELREXFIO · EPKINLY · ERLEADA · Elahere · Epkinly · Erleada · FOTIVDA · GAVRETO · GAZYVA · Gazyva · HYQVIA · Halaven · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · KYPHON Balloon Kyphoplasty · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUPRON DEPOT · LYNPARZA · Lenvima · MEKINIST · MONOFERRIC · NINLARO · Nplate · Nubeqa · OPDIVO · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Onivyde · Orserdu · PADCEV · PIQRAY · PROMACTA · Perjeta · Pomalyst · Prometra II · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · Soliris · Stivarga · TAGRISSO · TALVEY · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Trodelvy · Udenyca · VENCLEXTA · Venclexta · Vitrakvi · Vonjo · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
52
County median income
$50,747
Nearest hospital to ZIP centroid (approximate)
ATRIUM HEALTH NAVICENT THE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sumrall is a mixed practice specialist, with above-average Medicare volume (top 1% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sumrall experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Sumrall performed 39,750 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sumrall receive payments from pharmaceutical companies?
Yes. Dr. Sumrall received a total of $34,895 from 70 companies across 396 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sumrall's costs compare to other opticians in Macon?
Dr. Sumrall's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sumrall) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Macon
Browse opticians in Macon ranked by procedure volume and transparency data.
Highest volume
Top Opticians in GA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in GA
Which GA opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology